KCL ACMS UKMLA Lecture Series 2
Summary
This on-demand teaching session by ACMSEducate is a comprehensive look at various medical conditions, focusing primarily on Diabetes Mellitus Type 1 and Type 2, Osteoporosis, and Meningitis. The session covers the pathophysiology, symptoms, investigations/diagnostic methods, and management for each condition, providing valuable information for medical professionals seeking up-to-date, well-rounded knowledge of these prevalent health issues. Importantly, the discussion on diabetes delves into both pharmacological and lifestyle management, while the osteoporosis section outlines various investigations including DEXA scans and FRAX scores. The talk on meningitis also covers important signs and diagnostic tests. This session promises to be an enriching educational experience for all attendees.
Learning objectives
- Understand the pathophysiology of the diseases presented in the lecture, including Diabetes Mellitus Type 1, Diabetes Mellitus Type 2, Osteoporosis, and Meningitis.
- Identify the key signs and symptoms associated with the diseases covered in the teaching session and understand how they may present in different patients.
- Recognise the appropriate diagnostic processes for each of the diseases, including the specific investigations needed and how to interpret results.
- Formulate a comprehensive management plan for patients suffering from these diseases, including pharmacological intervention and lifestyle modifications.
- Understand the potential complications associated with the diseases and how to prevent or manage them to improve patient outcomes.
Similar communities
Similar events and on demand videos
Computer generated transcript
Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.
ACMSEducate UKMLA Lecture Series (ACMS Secretary)aConditions Endocrine Musculoskeletal 01 Diabetes Mellitus Type 1 02 Osteoporosis Diabetes Mellitus Type 2 Infectious Diseases 03 MeningitisStructure of Lecture A Pathophysiology Why does this disease occur B Signs/Symptoms How does this disease present C Investigations How do we diagnose it Management D How do we manage the disease 01a Diabetes Mellitus Type 1 (Endocrine)Diabetes Mellitus Type 1 - Pathophysiology Autoimmune destruction of pancreatic beta cells.Insulin deficiency leads to impaired glucose uptake by cells. Risk Factors Genetic predisposition. Vitamin D Exposure Viral infections - Enteroviruses Diabetes Mellitus Type 1 - Signs/Symptoms ● Polydipsia (Excessive Thirst) ● Weight ● Polyuria Loss (Excessive Urination)Diabetes Mellitus Type 1 - Investigations If SYMPTOMATIC, one of the following results is sufficient for diagnosis: Random blood glucose (Taken randomly) ≥ 11.1mmol/l or Fasting plasma glucose (After fasting 8-12 hours)≥ 7mmol/l 2-hour glucose tolerance (Taken 2 hours after ingesting glucose solution) ≥ 11.1mmol/l HbA1C (Amount of Glucose on Hb) ≥ 48mmol/mol (6.5%) If the patient is ASYMPTOMATIC, two results are required from different daysDiabetes Mellitus Type 1 - Management Pharmacological ● Insulin Therapy ● Blood Pressure Control ● Hypoglycemia Management Lifestyle ● Blood Glucose Monitoring ● Regular Follow-Up ● Psychosocial Support ● Exercise ● Healthy Diet ● Smoking Cessation 01b Diabetes Mellitus Type 2 (Endocrine)Diabetes Mellitus Type 2 - Pathophysiology A chronic metabolic condition characterized by inadequate insulin production from pancreatic beta cells, resulting in insulin resistance. This leads to an elevation in blood glucose levels, causing hyperglycemia.Diabetes Mellitus Type 2 - Signs/Symptoms Individuals with T2DM may initially be asymptomatic, but over time, they may develop: ● Polyuria ● Polydipsia ● Unexplained weight loss ● Blurry vision ● FatigueDiabetes Mellitus Type 2 - Investigations If symptomatic, one of the following results is sufficient for diagnosis: ● Random blood glucose ≥ 11.1mmol/l ● Fasting plasma glucose ≥ 7mmol/l ● 2-hour glucose tolerance ≥ 11.1mmol/l ● HbA1C ≥ 48mmol/mol (6.5%) If the patient is asymptomatic, two results are required from different days.Diabetes Mellitus Type 2 - Management Pharmacological Intervention Medication Types ● SGLT-2 Inhibitors (-flozins) => Lowers blood sugar by blocking reabsorption of glucose e.g Dapagliflozin ● DPP-4 Inhibitors (-gliptins) => Blocks DPP4 which destroys Incretin (Helps produce insulin) -> Increased incretin -> Increased Insulin e.g Sitagliptin ● Sulphonylureas (-zides) => Stimulate pancreatic beta cells to release insulin e.g Gliclazide ● Thiazolidinediones (-zones) => Decrease Insulin resistance e.g Pioglitazone ● Metformin => Inhibit hepatic gluconeogenesis & oppose action of glucagonDiabetes Mellitus Type 2 - Management Pharmacological Intervention First Line Therapy => MetforminDiabetes Mellitus Type 2 - Management Blood Pressure targets in Diabetes Blood pressure control needs to be strict in diabetes because these patients are at higher risk of macro- and microvascular complications. NICE Hypertension Guidance sets the same blood pressure targets as those who do not have diabetes below 140/90 mmHg , however in diabetics with Hypertension, ACE-inhibitors are first line as they are reno-protective OR ARB if patient has a black African or African-Caribbean family originDiabetes - Complications Macrovascular ● Cardiac Complications (Congestive HF,Diabetic Cardiomyopathy) ● PAD (Peripheral Artery Disease) ● Cerebrovascular Disease Microvascular ● Diabetic Retinopathy - Complications in the eyes due to diabetes ● Diabetic Neuropathy - Nerve damage that occurs due to diabetes ● Gastrointestinal Complications - GERD , Gastroparesis,NAFLD ,Enteropathy ● Foot Complications - Gout ● Sexual Dysfunction 02 Osteoporosis (Musculoskeletal)Osteoporosis - Pathophysiology Loss of bone density and microarchitectural deterioration => Leading to increase bone fragility and a consequent increase in fracture riskOsteoporosis - Signs/Symptoms ● Back pain, (Caused by a fractured or collapsed vertebra) ● Loss of height over time ● A stooped posture ● Bone Fractures (Occurs much more easily than expected)Osteoporosis - Investigations Gold Standard Investigation ● DEXA scan with a T-score of -2.5 or lower indicating osteoporosisOsteoporosis - Investigations Other Investigations ● X-rays - For suspected fractures ● MRI of the spine - Assessment of vertebral fractures ● Blood tests - To exclude metabolic bone diseases and assess - Vitamin D - Calcium - Hormone levelsOsteoporosis - Investigations FRAX Score The FRAX (Fracture Risk Assessment Tool) score is used to estimate the 10-year probability of a major osteoporotic fracture. Interpretation of FRAX scores: Normal: 10-year probability <10% Osteopenia (low bone density): 10-year probability 10-20% Osteoporosis: 10-year probability >20%Osteoporosis - Lifestyle Management Management of osteoporosis involves lifestyle modifications and pharmacological treatment. Lifestyle modifications: Reducing risk factors - Smoking Cessation - Diabetic Control Ensuring adequate intake of 1.Vitamin D 2.Calcium 3.Protein Regular weight-bearing exercise - Use of hip protectors in nursing home patientsOsteoporosis - Pharmacological Management Pharmacological treatment includes: Bisphosphonates First-line treatment for osteoporosis. For individuals with - Fragility fracture - T-score of -2.5 or lower or a T-score between -1 and -2.5 with a 10-year probability of a major osteoporotic fracture of 20% or higher or a hip fracture probability of 3% or higher based on the FRAX score.Osteoporosis - Bisphosphonates Side effects ● Gastrointestinal symptoms (e.g. dyspepsia, oesophagitis) ● Musculoskeletal pain ● Osteonecrosis (Loss of blood supply to bone) of the jaw and atypical femoral fractures (RARE) 03 Meningitis (Infectious Disease)Meningitis - Pathophysiology Meningitis is an inflammation of the meninges Layers of Meninges ● Dura Mater ● Arachnoid Mater ● Pia MaterMeningitis - Sign/Symptoms ● Headache ● Fever ● Neck stiffness ● Photophobia ● Nausea and vomiting ● Focal neurology ● Seizures ● Reduced conscious level ● Non-Blanching petechial rash Meningitis - Investigations Both are used to test for meningeal irritation Kernig’s Sign Brudzinski Sign Pain and/or Resistance to knee flexion Involuntary knee and hip flexion in => POSITIVE Kernig’s Sign response to neck flexion => POSITIVE Brudzinski SignMeningitis - Investigations Diagnostic investigations for suspected meningitis include: - Blood tests - FBC,U&Es, Clotting, Glucose - ABG - Blood cultures - Imaging: CT Head - Lumbar puncture for Cerebrospinal Fluid (CSF) analysisMeningitis - Management 2g of IV ceftriaxone twice daily - to ensure CNS penetration IV amoxicillin (Contains Penicillin) - added in patients at age extremes for listeria* coverage. *Listeria is a bacteria and is also a common cause of meningitis in Neonates and the elderly In cases of suspected viral encephalitis (Brain inflammation) - IV Aciclovir should also be administered. Patients allergic to penicillin => Chloramphenicol administered instead THANKS FOR LISTENING !! CREDITS: This presentation template was created by Slidesgo, including icons by Flaticon and infographics & images by Freepik